Target-controlled infusion (TCI) is a new delivery system for IV anaes
thetic agents with which the anaesthetist targets a plasma drug concen
tration to achieve a predetermined effect. With this sytem, the tediou
s task of calculating the amount of administered drug required to achi
eve the target concentration is left in charge of a microprocessor whi
ch commands the infusion device. TCI has long been used only by a few
research teams, but this year a much wider field opens to this deliver
y system through marketing of Diprifusor(TM), a TCI system specificall
y designed for administration of propofol in everyday practice. This a
rticle describes the rationale for administering IV agents through TCI
delivery systems, the pharmacokinetic basis of TCI, the regulations a
nd a broad overview of clinical applications, both recent and yet to c
ome.